Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Piekielko-Witkowska A et al. - The results show that the expression and alternative splicing of DIO1 mRNA is disturbed in renal cancer, possibly due to changes in expression of splicing factors SF2/ASF and hnRNPA1.

Related Articles

A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment
Cancer Chemotherapy and Pharmacology, 11/18/09    Relevance Score: 68%

Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09    Relevance Score: 68%

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09    Relevance Score: 68%

Incidence of Cancer in Finnish Families with Clinically Aggressive and Nonaggressive Prostate Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09    Relevance Score: 67%

The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09    Relevance Score: 67%

Today in Basic Science/Genetics...keeping you current

Targeting the RET Pathway in Thyroid Cancer
Clinical Cancer Research, 12/01/09

Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI
Diabetes, 11/30/09

Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address